FONAR Corporation (FONR)
USD 13.49
(-2.25%)
USD 13.49
(-2.25%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 | -14.66 Million USD | -2.76% |
| 2023 | -14.27 Million USD | -35.82% |
| 2022 | -10.5 Million USD | -7.59% |
| 2021 | -9.76 Million USD | -850.04% |
| 2020 | -1.02 Million USD | 92.42% |
| 2019 | -13.56 Million USD | 29.77% |
| 2018 | -19.31 Million USD | -100.77% |
| 2017 | -9.62 Million USD | -139.29% |
| 2016 | -4.02 Million USD | -219.32% |
| 2015 | -1.25 Million USD | -188.63% |
| 2014 | 1.42 Million USD | -82.02% |
| 2013 | 7.9 Million USD | 184.05% |
| 2012 | -9.4 Million USD | -71.58% |
| 2011 | -5.47 Million USD | -644.24% |
| 2010 | 1 Million USD | 1882.91% |
| 2009 | 50.77 Thousand USD | 125.93% |
| 2008 | -195.81 Thousand USD | 58.57% |
| 2007 | -472.69 Thousand USD | 85.0% |
| 2006 | -3.15 Million USD | 23.61% |
| 2005 | -4.12 Million USD | -48.84% |
| 2004 | -2.77 Million USD | 62.57% |
| 2003 | -7.4 Million USD | -337.67% |
| 2002 | 3.11 Million USD | -52.89% |
| 2001 | 6.61 Million USD | -27.79% |
| 2000 | 9.15 Million USD | -4.6% |
| 1999 | 9.6 Million USD | 137.21% |
| 1998 | -25.8 Million USD | -1884.62% |
| 1997 | -1.3 Million USD | -533.33% |
| 1996 | 300 Thousand USD | -40.0% |
| 1995 | 500 Thousand USD | -90.74% |
| 1994 | 5.4 Million USD | -43.75% |
| 1993 | 9.6 Million USD | -17.95% |
| 1992 | 11.7 Million USD | -20.41% |
| 1991 | 14.7 Million USD | -16.48% |
| 1990 | 17.6 Million USD | -15.38% |
| 1989 | 20.8 Million USD | 1633.33% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q3 | -13.07 Million USD | 24.84% |
| 2024 Q2 | -17.4 Million USD | -16.3% |
| 2024 Q1 | -14.96 Million USD | -4.84% |
| 2024 Q4 | -14.66 Million USD | -12.13% |
| 2023 Q4 | -14.27 Million USD | -19.07% |
| 2023 FY | -14.27 Million USD | -35.82% |
| 2023 Q1 | -10.49 Million USD | 0.17% |
| 2023 Q2 | -11.29 Million USD | -7.65% |
| 2023 Q3 | -11.98 Million USD | -6.14% |
| 2022 Q4 | -10.5 Million USD | -43.77% |
| 2022 Q1 | -10.01 Million USD | -2.56% |
| 2022 Q2 | -6.2 Million USD | 38.02% |
| 2022 Q3 | -7.3 Million USD | -17.72% |
| 2022 FY | -10.5 Million USD | -7.59% |
| 2021 Q4 | -9.76 Million USD | -44.14% |
| 2021 Q3 | -6.77 Million USD | -5.74% |
| 2021 Q2 | -6.4 Million USD | -72.3% |
| 2021 Q1 | -3.71 Million USD | -261.75% |
| 2021 FY | -9.76 Million USD | -850.04% |
| 2020 Q2 | 16.76 Million USD | -12.34% |
| 2020 Q3 | 361 Thousand USD | -97.85% |
| 2020 Q4 | -1.02 Million USD | -384.78% |
| 2020 Q1 | 19.12 Million USD | 240.94% |
| 2020 FY | -1.02 Million USD | 92.42% |
| 2019 Q4 | -13.56 Million USD | 44.52% |
| 2019 FY | -13.56 Million USD | 29.77% |
| 2019 Q1 | -20.85 Million USD | -8.09% |
| 2019 Q2 | -22.95 Million USD | -10.11% |
| 2019 Q3 | -24.45 Million USD | -6.53% |
| 2018 Q1 | -10.87 Million USD | -12.98% |
| 2018 Q4 | -19.28 Million USD | -28.19% |
| 2018 Q3 | -15.04 Million USD | -9.23% |
| 2018 Q2 | -13.77 Million USD | -26.71% |
| 2018 FY | -19.31 Million USD | -100.77% |
| 2017 Q1 | -4.89 Million USD | -21.77% |
| 2017 Q2 | -5.6 Million USD | -14.5% |
| 2017 FY | -9.62 Million USD | -139.29% |
| 2017 Q4 | -9.62 Million USD | -44.16% |
| 2017 Q3 | -6.67 Million USD | -19.05% |
| 2016 FY | -4.02 Million USD | -219.32% |
| 2016 Q1 | -3.4 Million USD | -170.54% |
| 2016 Q4 | -4.02 Million USD | 41.11% |
| 2016 Q2 | -6.01 Million USD | -76.46% |
| 2016 Q3 | -6.82 Million USD | -13.59% |
| 2015 FY | -1.25 Million USD | -188.63% |
| 2015 Q2 | -1.84 Million USD | -774.41% |
| 2015 Q3 | 1.37 Million USD | 174.74% |
| 2015 Q1 | -211 Thousand USD | -114.85% |
| 2015 Q4 | -1.25 Million USD | -191.32% |
| 2014 FY | 1.42 Million USD | -82.02% |
| 2014 Q4 | 1.42 Million USD | -48.92% |
| 2014 Q2 | 4.15 Million USD | -25.37% |
| 2014 Q1 | 5.56 Million USD | -29.58% |
| 2014 Q3 | 2.78 Million USD | -33.01% |
| 2013 Q2 | -12.64 Million USD | -19.94% |
| 2013 Q3 | 6.67 Million USD | 152.82% |
| 2013 Q4 | 7.9 Million USD | 18.33% |
| 2013 FY | 7.9 Million USD | 184.05% |
| 2013 Q1 | -10.54 Million USD | -12.12% |
| 2012 Q1 | -6.06 Million USD | -10.71% |
| 2012 Q2 | -6.78 Million USD | -11.85% |
| 2012 Q3 | -8.32 Million USD | -22.71% |
| 2012 Q4 | -9.4 Million USD | -12.91% |
| 2012 FY | -9.4 Million USD | -71.58% |
| 2011 FY | -5.47 Million USD | -644.24% |
| 2011 Q4 | -5.47 Million USD | -408.51% |
| 2011 Q3 | 1.77 Million USD | -18.38% |
| 2011 Q2 | 2.17 Million USD | 93.25% |
| 2011 Q1 | 1.12 Million USD | 11.85% |
| 2010 Q4 | 1 Million USD | -46.45% |
| 2010 Q3 | 1.88 Million USD | 1392.06% |
| 2010 Q2 | 126 Thousand USD | -75.05% |
| 2010 Q1 | 505 Thousand USD | 894.66% |
| 2010 FY | 1 Million USD | 1882.91% |
| 2009 Q1 | -2.81 Million USD | -1336.06% |
| 2009 Q4 | 50.77 Thousand USD | 108.15% |
| 2009 FY | 50.77 Thousand USD | 125.93% |
| 2009 Q2 | -1.56 Million USD | 44.38% |
| 2009 Q3 | -623 Thousand USD | 60.17% |
| 2008 Q2 | -386 Thousand USD | -14.2% |
| 2008 Q1 | -338 Thousand USD | 28.49% |
| 2008 Q3 | -895 Thousand USD | -131.87% |
| 2008 Q4 | -195.81 Thousand USD | 78.12% |
| 2008 FY | -195.81 Thousand USD | 58.57% |
| 2007 Q3 | -1.56 Million USD | 57.27% |
| 2007 Q2 | -3.65 Million USD | -32.98% |
| 2007 Q1 | -2.74 Million USD | 12.82% |
| 2007 Q4 | -472.69 Thousand USD | 69.72% |
| 2007 FY | -472.69 Thousand USD | 85.0% |
| 2006 Q3 | -2.21 Million USD | 66.59% |
| 2006 Q4 | -3.15 Million USD | -42.13% |
| 2006 FY | -3.15 Million USD | 23.61% |
| 2006 Q1 | -3.1 Million USD | 24.8% |
| 2006 Q2 | -6.63 Million USD | -113.93% |
| 2005 Q3 | -5.54 Million USD | -241.74% |
| 2005 FY | -4.12 Million USD | -48.84% |
| 2005 Q4 | -4.12 Million USD | 25.58% |
| 2005 Q2 | -1.62 Million USD | 48.98% |
| 2005 Q1 | -3.17 Million USD | -14.7% |
| 2004 Q4 | -2.77 Million USD | -1398.11% |
| 2004 FY | -2.77 Million USD | 62.57% |
| 2004 Q1 | -7.9 Million USD | -6.71% |
| 2004 Q2 | -11.42 Million USD | -44.55% |
| 2004 Q3 | -185 Thousand USD | 98.38% |
| 2003 FY | -7.4 Million USD | -337.67% |
| 2003 Q4 | -7.4 Million USD | -275.14% |
| 2003 Q1 | 1.6 Million USD | -48.61% |
| 2003 Q2 | 4.08 Million USD | 155.15% |
| 2003 Q3 | 4.22 Million USD | 3.5% |
| 2002 Q1 | 11.64 Million USD | 76.0% |
| 2002 Q2 | 11.21 Million USD | -3.63% |
| 2002 Q4 | 3.11 Million USD | -57.96% |
| 2002 Q3 | 7.41 Million USD | -33.94% |
| 2002 FY | 3.11 Million USD | -52.89% |
| 2001 Q3 | 7.01 Million USD | 27.62% |
| 2001 Q4 | 6.61 Million USD | -5.71% |
| 2001 FY | 6.61 Million USD | -27.79% |
| 2001 Q2 | 5.49 Million USD | 137.2% |
| 2001 Q1 | 2.31 Million USD | -74.7% |
| 2000 FY | 9.15 Million USD | -4.6% |
| 2000 Q4 | 9.15 Million USD | -39.86% |
| 2000 Q3 | 15.22 Million USD | 1.52% |
| 2000 Q2 | 15 Million USD | 10.29% |
| 2000 Q1 | 13.6 Million USD | 41.67% |
| 1999 Q3 | 6.3 Million USD | 352.0% |
| 1999 Q1 | -9 Million USD | 65.12% |
| 1999 FY | 9.6 Million USD | 137.21% |
| 1999 Q4 | 9.6 Million USD | 52.38% |
| 1999 Q2 | -2.5 Million USD | 72.22% |
| 1998 Q4 | -25.8 Million USD | 51.5% |
| 1998 FY | -25.8 Million USD | -1884.62% |
| 1998 Q1 | -75.7 Million USD | -5723.08% |
| 1998 Q2 | -70.7 Million USD | 6.61% |
| 1998 Q3 | -53.2 Million USD | 24.75% |
| 1997 Q2 | -6.3 Million USD | -625.0% |
| 1997 Q4 | -1.3 Million USD | 65.79% |
| 1997 Q1 | 1.2 Million USD | 300.0% |
| 1997 Q3 | -3.8 Million USD | 39.68% |
| 1997 FY | -1.3 Million USD | -533.33% |
| 1996 Q1 | 1.9 Million USD | 280.0% |
| 1996 FY | 300 Thousand USD | -40.0% |
| 1996 Q4 | 300 Thousand USD | 130.0% |
| 1996 Q3 | -1 Million USD | -134.48% |
| 1996 Q2 | 2.9 Million USD | 52.63% |
| 1995 Q2 | 4.3 Million USD | -10.42% |
| 1995 Q1 | 4.8 Million USD | -11.11% |
| 1995 Q3 | 4 Million USD | -6.98% |
| 1995 Q4 | 500 Thousand USD | -87.5% |
| 1995 FY | 500 Thousand USD | -90.74% |
| 1994 Q4 | 5.4 Million USD | -15.63% |
| 1994 FY | 5.4 Million USD | -43.75% |
| 1994 Q3 | 6.4 Million USD | -14.67% |
| 1994 Q1 | 9 Million USD | -6.25% |
| 1994 Q2 | 7.5 Million USD | -16.67% |
| 1993 Q1 | 11.2 Million USD | -4.27% |
| 1993 Q2 | 10.3 Million USD | -8.04% |
| 1993 Q3 | 9.7 Million USD | -5.83% |
| 1993 Q4 | 9.6 Million USD | -1.03% |
| 1993 FY | 9.6 Million USD | -17.95% |
| 1992 Q3 | 12.5 Million USD | 76.06% |
| 1992 FY | 11.7 Million USD | -20.41% |
| 1992 Q1 | 14 Million USD | -4.76% |
| 1992 Q2 | 7.1 Million USD | -49.29% |
| 1992 Q4 | 11.7 Million USD | -6.4% |
| 1991 Q1 | 9.8 Million USD | -44.32% |
| 1991 Q4 | 14.7 Million USD | 59.78% |
| 1991 Q2 | 7.9 Million USD | -19.39% |
| 1991 FY | 14.7 Million USD | -16.48% |
| 1991 Q3 | 9.2 Million USD | 16.46% |
| 1990 Q4 | 17.6 Million USD | 33.33% |
| 1990 Q3 | 13.2 Million USD | -8.97% |
| 1990 FY | 17.6 Million USD | -15.38% |
| 1990 Q2 | 14.5 Million USD | 0.0% |
| 1989 FY | 20.8 Million USD | 1633.33% |
| 1989 Q4 | 20.8 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 27.08 Million USD | 154.152% |
| BrainsWay Ltd. | -10.32 Million USD | -42.106% |
| Cerus Corporation | 84.35 Million USD | 117.386% |
| Envoy Medical, Inc. | -3.81 Million USD | -284.513% |
| electroCore, Inc. | -9.95 Million USD | -47.316% |
| Helius Medical Technologies, Inc. | -5.12 Million USD | -186.153% |
| IceCure Medical Ltd | -9.93 Million USD | -47.628% |
| Inogen, Inc. | -103.56 Million USD | 85.84% |
| OrthoPediatrics Corp. | -9.26 Million USD | -58.253% |
| Lucid Diagnostics Inc. | -3.64 Million USD | -302.783% |
| Monogram Orthopaedics, Inc. | -13.09 Million USD | -11.974% |
| MaxCyte, Inc. | -27.76 Million USD | 47.177% |
| NeuroOne Medical Technologies Corporation | -5.13 Million USD | -185.423% |
| Nexalin Technology, Inc. | -575.76 Thousand USD | -2447.094% |
| Orthofix Medical Inc. | 96.44 Million USD | 115.206% |
| PAVmed Inc | 29.08 Million USD | 150.421% |
| Rapid Micro Biosystems, Inc. | -16.93 Million USD | 13.423% |
| RxSight, Inc. | -6.68 Million USD | -119.541% |
| Sight Sciences, Inc. | -102.71 Million USD | 85.722% |
| SI-BONE, Inc. | 5.72 Million USD | 356.342% |
| TELA Bio, Inc. | -3.94 Million USD | -271.368% |
| Treace Medical Concepts, Inc. | 57.32 Million USD | 125.585% |
| Vivos Therapeutics, Inc. | 352 Thousand USD | 4266.285% |
| Acutus Medical, Inc. | 12.27 Million USD | 219.434% |
| Talis Biomedical Corporation | -57.06 Million USD | 74.3% |
| Spectral AI, Inc. | -3.5 Million USD | -318.89% |
| Nano-X Imaging Ltd. | -48.02 Million USD | 69.464% |
| CVRx, Inc. | -59.95 Million USD | 75.54% |
| DIH Holding US, Inc. Warrants | 1.98 Million USD | 839.126% |
| PetVivo Holdings, Inc. | 1.27 Million USD | 1247.847% |
| Bioventus Inc. | 372.51 Million USD | 103.937% |
| Venus Concept Inc. | 74.3 Million USD | 119.738% |
| TriSalus Life Sciences, Inc. | -10.18 Million USD | -44.032% |
| LivaNova PLC | 62.53 Million USD | 123.453% |
| 908 Devices Inc. | -115.09 Million USD | 87.258% |
| Alphatec Holdings, Inc. | 320.7 Million USD | 104.573% |
| Nemaura Medical Inc. | 9.92 Million USD | 247.761% |
| NeuroPace, Inc. | 54.33 Million USD | 126.99% |
| LENSAR, Inc. | -18.31 Million USD | 19.914% |
| Apyx Medical Corporation | -5.15 Million USD | -184.708% |
| Cutera, Inc. | 288.3 Million USD | 105.087% |
| STRATA Skin Sciences, Inc. | 7.51 Million USD | 295.147% |
| BioSig Technologies, Inc. | 262 Thousand USD | 5697.452% |
| Anika Therapeutics, Inc. | -43.83 Million USD | 66.54% |
| ClearPoint Neuro, Inc. | -9.19 Million USD | -59.423% |
| Integra LifeSciences Holdings Corporation | 1.4 Billion USD | 101.044% |
| Axonics, Inc. | -77.19 Million USD | 81.002% |
| Outset Medical, Inc. | 67.67 Million USD | 121.669% |
| IRIDEX Corporation | -4.28 Million USD | -242.008% |
| PROCEPT BioRobotics Corporation | -178.01 Million USD | 91.762% |
| IRadimed Corporation | -47.71 Million USD | 69.267% |
| Tivic Health Systems, Inc. | -3.02 Million USD | -384.644% |
| INVO Bioscience, Inc. | 8.45 Million USD | 273.531% |
| Telesis Bio, Inc. | 32.63 Million USD | 144.937% |
| Viemed Healthcare, Inc. | -2.5 Million USD | -486.113% |
| Varex Imaging Corporation | 316.9 Million USD | 104.628% |
| Quipt Home Medical Corp. | 81.73 Million USD | 117.943% |
| Inspira Technologies Oxy B.H.N. Ltd. | -2.78 Million USD | -427.15% |
| Pulmonx Corporation | -42.36 Million USD | 65.379% |
| Dynatronics Corporation | 6.2 Million USD | 336.384% |
| Modular Medical, Inc. | -8.04 Million USD | -82.359% |
| ReShape Lifesciences Inc. | -4.29 Million USD | -241.292% |
| Semler Scientific, Inc. | -57.13 Million USD | 74.33% |
| InMode Ltd. | -135.39 Million USD | 89.168% |
| Bruker Corporation | 891.3 Million USD | 101.645% |
| Cytosorbents Corporation | 4.18 Million USD | 450.676% |
| DexCom, Inc. | 2.02 Billion USD | 100.723% |
| Align Technology, Inc. | -840.47 Million USD | 98.255% |
| Viveve Medical, Inc. | -13.81 Million USD | -6.17% |
| ZimVie Inc. | 450.41 Million USD | 103.256% |
| Movano Inc. | -5.86 Million USD | -150.006% |
| Cytek Biosciences, Inc. | -134.45 Million USD | 89.093% |
| Nexalin Technology, Inc. | -575.76 Thousand USD | -2447.094% |
| DIH Holdings US, Inc. Class A Common Stock | 1.98 Million USD | 839.126% |
| Tandem Diabetes Care, Inc. | 356.79 Million USD | 104.11% |
| Profound Medical Corp. | -18.17 Million USD | 19.326% |
| Insulet Corporation | 798.1 Million USD | 101.838% |
| enVVeno Medical Corporation | -2.21 Million USD | -561.196% |
| Surmodics, Inc. | -12.01 Million USD | -22.069% |
| iCAD, Inc. | -21.2 Million USD | 30.853% |
| Nuwellis, Inc. | -2.81 Million USD | -420.231% |
| Biotricity, Inc. | 23.09 Million USD | 163.506% |
| iRhythm Technologies, Inc. | 93.65 Million USD | 115.66% |
| Aethlon Medical, Inc. | -4.5 Million USD | -225.776% |
| InspireMD, Inc. | -8.04 Million USD | -82.291% |
| PAVmed Inc. | 29.08 Million USD | 150.421% |
| BIOLASE, Inc. | 11.34 Million USD | 229.278% |
| Beyond Air, Inc. | 6.22 Million USD | 335.436% |
| AxoGen, Inc. | 32.26 Million USD | 145.451% |
| Vivani Medical, Inc. | 42 Thousand USD | 35017.438% |
| Tactile Systems Technology, Inc. | -10.65 Million USD | -37.599% |
| Inari Medical, Inc. | -7.16 Million USD | -104.794% |
| UFP Technologies, Inc. | 40.77 Million USD | 135.967% |
| QT Imaging Holdings, Inc. | 3.06 Million USD | 577.912% |
| Heart Test Laboratories, Inc. | -4.77 Million USD | -207.365% |
| Tenon Medical, Inc. | -1.25 Million USD | -1068.552% |
| Autonomix Medical, Inc. Common Stock | -7.6 Million USD | -92.813% |
| Co-Diagnostics, Inc. | -11.92 Million USD | -22.966% |
| AdaptHealth Corp. | 2.21 Billion USD | 100.661% |
| Sintx Technologies, Inc. | 905 Thousand USD | 1720.478% |
| NanoVibronix, Inc. | -3.27 Million USD | -347.386% |
| Quanterix Corporation | -132.95 Million USD | 88.97% |
| Inspira Technologies Oxy B.H.N. Ltd. | -2.78 Million USD | -427.15% |
| Sensus Healthcare, Inc. | -22.36 Million USD | 34.427% |
| Pacific Biosciences of California, Inc. | 753.71 Million USD | 101.946% |
| TransMedics Group, Inc. | 121.13 Million USD | 112.107% |
| ReWalk Robotics Ltd. | -26.18 Million USD | 43.983% |
| NeuroMetrix, Inc. | -1.49 Million USD | -883.544% |
| Hyperfine, Inc. | -75.61 Million USD | 80.606% |
| Establishment Labs Holdings Inc. | 152.18 Million USD | 109.636% |
| Biomerica, Inc. | -3.38 Million USD | -333.244% |
| Bone Biologics Corporation | -3.02 Million USD | -384.553% |
| AVITA Medical, Inc. | -26.23 Million USD | 44.093% |
| Bluejay Diagnostics, Inc. | -1.83 Million USD | -697.717% |
| Silk Road Medical, Inc | 64.42 Million USD | 122.764% |